11-118344461-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000073.3(CD3G):c.38C>T(p.Ala13Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000127 in 1,570,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A13T) has been classified as Uncertain significance.
Frequency
Consequence
NM_000073.3 missense
Scores
Clinical Significance
Conservation
Publications
- combined immunodeficiency due to CD3gamma deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD3G | NM_000073.3 | c.38C>T | p.Ala13Val | missense_variant | Exon 1 of 7 | ENST00000532917.3 | NP_000064.1 | |
CD3G | NM_001440319.1 | c.38C>T | p.Ala13Val | missense_variant | Exon 1 of 7 | NP_001427248.1 | ||
CD3G | XM_005271724.5 | c.38C>T | p.Ala13Val | missense_variant | Exon 1 of 4 | XP_005271781.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 7.05e-7 AC: 1AN: 1417794Hom.: 0 Cov.: 31 AF XY: 0.00000143 AC XY: 1AN XY: 700748 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74362 show subpopulations
ClinVar
Submissions by phenotype
Combined immunodeficiency due to CD3gamma deficiency Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CD3G-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with valine at codon 13 of the CD3G protein (p.Ala13Val). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and valine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at